USPTO 2015–2025 USPTO PatentsView US Corporation

Anthrogenesis Corporation

USPTO PatentsView assignee record - 22 granted patents across 13 technology areas, recorded in grant years 2015–2017. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media).

RSS updates for this company

The verdict

According to USPTO PatentsView, Anthrogenesis ranks #13,300 of 49,997 tracked US assignees by granted-patent volume, with 22 patents across 13 technology areas.

#13,300
of 49,997 US assignees by volume
45th percentile
by Innovation Score (33.5/100)
16.6
avg claims per patent
-100%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R13300 · US Corporation #13,300 · 22 grants

GRANTS-SMALL · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-DROP · BOOK-FULL

  • GRANTS-SMALL 22 grants
  • MID-PACK #13,300/49,997
  • PHOTO-FINISH Alcatel-Lucent…
  • CPC-FOCUS C12N · 13 areas
  • INNOV-THIN 33.5/100
  • CLAIMS-RICH 16.6 claims/avg
  • TYPE-USCORP US Corporation
  • VEL-DROP -100% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: Alcatel-Lucent Shanghai Bell Co., Ltd. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Anthrogenesis’s 33.5 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Innovation-score neighbourhood around Anthrogenesis

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Anthrogenesis's Innovation Score is 33.5/100 (45th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Does more volume mean deeper claims for Anthrogenesis?

Each dot is one of Anthrogenesis’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Anthrogenesis’s own 16.6 claims/patent is at or below the 17.7 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Anthrogenesis vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView. 2×2 strategic matrix plotting 9 entities by Granted patents (volume) (X) and Avg claims / patent (Y), with a crosshair dividing the plot into four quadrants. Volume + depthSelective & thoroughVolume over depthLean filer 21.921.92222.1 510152025 Granted patents (volume) Avg claims / patent Alcatel-Lucent Shanghai Bell Co., Ltd. - 22, 18.32Alcatel-lucent Sh…Alpha Tau Medical Ltd. - 22, 17.86Alpha Tau MedicalAltus Intervention (Technologies) AS - 22, 13.09Altus Interventio…Anhui Agricultural University - 22, 5.77Anhui Agricultura…Applied Nanostructured Solutions, LLC - 22, 16.41Applied Nanostruc…Apptimize LLC - 22, 19.64ApptimizeArmorworks Holdings, Inc. - 22, 17.73Armorworks Holdin…Associated Universities, Inc. - 22, 19.55Associated Univer…Anthrogenesis Corporation - 22, 16.59Anthrogenesis
Anthrogenesis vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Anthrogenesis's grants concentrate

Anthrogenesis Corporation is a focused PatentsView assignee: 13 CPC subclasses with 90.9% of grants classified under C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media). Peak complete grant year is 2015 (10 grants) versus a trough of 6 in 2016. By volume, Anthrogenesis sits between Alcatel-Lucent Shanghai Bell Co., Ltd. and Associated Universities, Inc..

Who files at Anthrogenesis's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Anthrogenesis holds 22 patents at rank #13,304, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Anthrogenesis

By rank, the assignees closest to #13,304 in granted patent volume.

Leaders in C12N (Microorganisms OR Enzymes)

Other assignees with the most granted patents in Anthrogenesis's primary technology class.

Anthrogenesis's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

34 45th percentile higher than 45% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

567891011 201520162017 6
USPTO utility patent grants by year · 2015–2017

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
Anthrogenesis Corporation patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 10 45.5%
2016 6 27.3%
2017 6 27.3%

Which technologies does Anthrogenesis Corporation patent most?

Top 13 of 13 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

What to do with this data

Anthrogenesis Corporation's patent record in context - here's where to go next.

  • Anthrogenesis Corporation's lead technology class is C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media), 90.9% of its portfolio - see every assignee active in that class. Explore C12N
  • Ranked #13,300 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Anthrogenesis Corporation against Alcatel-Lucent Shanghai Bell Co., Ltd., an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 33.5/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.